|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/18 |
| (11) | Patento numeris | 2802355 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13703151.4 |
| Europos patento paraiškos padavimo data | 2013-01-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-11-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2013/050131 |
| Data | 2013-01-07 |
| (87) | Numeris | WO 2013/105013 |
| Data | 2013-07-18 |
| (30) | Numeris | Data | Šalis |
| 201261584675 P | 2012-01-09 | US |
| (72) |
LAURENT, Olivier Alexandre, US
LEE, Alice, US
PRESTON, Richard Ryan, US
TUMELTY, David, US
YU, Wei Hong, US
BHAT, Abhijit Suresh, US
TEMPCZYK-RUSSELL, Anna, US
|
| (73) |
Pfizer Healthcare Ireland,
9 Riverwalk National Digital Park Citywest Business Campus, Dublin 24,
IE
|
| (54) | MUTANT ANTIBODIES AND CONJUGATION THEREOF |
| MUTANT ANTIBODIES AND CONJUGATION THEREOF |